Article
ASO targeting RBM3 temperature‐controlled poison exon splicing prevents neurodegeneration in vivo
22 Mar 2023
Abstract excerpt
Neurodegenerative diseases are increasingly prevalent in the aging population, yet no disease-modifying treatments are currently available. Increasing the expression of the cold-shock protein RBM3 through therapeutic hypothermia is remarkably neuroprotective. However, systemic cooling poses a health risk, strongly limiting its clinical application. Selective upregulation of RBM3 at normothermia thus holds immense...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
